本页面由Tiger Trade Technology Pte. Ltd.提供服务

Metagenomi Technologies, LLC

1.37
-0.0600-4.20%
盘后1.35-0.0200-1.46%18:44 EDT
成交量:24.30万
成交额:33.64万
市值:5,143.90万
市盈率:-0.58
高:1.43
开:1.41
低:1.36
收:1.43
52周最高:3.95
52周最低:1.23
股本:3,754.68万
流通股本:2,527.67万
量比:1.23
换手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):-2.3600
每股收益(LYR):-2.3634
净资产收益率:-44.67%
总资产收益率:-21.99%
市净率:0.32
市盈率(LYR):-0.58

数据加载中...

公司资料

公司名字:
Metagenomi Technologies, LLC
交易所:
NASDAQ
成立时间:
2016
员工人数:
119
公司地址:
5959 Horton Street,7th Floor,Emeryville,California,United States
邮编:
94608
电话:
传真:
- -
简介:
Metagenomi Therapeutics, Inc.最初于2016年9月成立,并于2018年作为特拉华州有限责任公司开始其现有业务。该公司是一家体内基因编辑公司,专注于利用从宏基因组学中获得的专有基因编辑工具开发治愈性基因药物。其全资主导项目MGX-001旨在治疗血友病A,并通过多种编辑方式持续推进针对遗传性疾病的研发管线。

董事

名称
职位
Brian C. Thomas
Co-Founder, Chief Executive Officer, Chair of the Board and Director
Jian Irish
President, Chief Operating Officer and Director
Willard Dere
Lead Independent Director
Eric Bjerkholt
Director
Juergen Eckhardt
Director

股东

名称
职位
Brian C. Thomas
Co-Founder, Chief Executive Officer, Chair of the Board and Director
Jian Irish
President, Chief Operating Officer and Director
Matthew L. Wein
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Pamela Wapnick
Chief Financial Officer
Sarah Noonberg
Chief Medical Officer